刘成凤, 徐燕, 都旭东. 高频超声测量参数与早期类风湿关节炎抗风湿疗效的相关性及预测价值分析[J]. 广西医科大学学报, 2023, 40(12): 2071-2077. DOI: 10.16190/j.cnki.45-1211/r.2023.12.021
引用本文: 刘成凤, 徐燕, 都旭东. 高频超声测量参数与早期类风湿关节炎抗风湿疗效的相关性及预测价值分析[J]. 广西医科大学学报, 2023, 40(12): 2071-2077. DOI: 10.16190/j.cnki.45-1211/r.2023.12.021
Liu Chengfeng, Xu Yan, Du Xudong. Correlation and predictive value of HFUS measurement parameters and anti-rheumatic efficacy of early rheumatoid arthritis[J]. Journal of Guangxi Medical University, 2023, 40(12): 2071-2077. DOI: 10.16190/j.cnki.45-1211/r.2023.12.021
Citation: Liu Chengfeng, Xu Yan, Du Xudong. Correlation and predictive value of HFUS measurement parameters and anti-rheumatic efficacy of early rheumatoid arthritis[J]. Journal of Guangxi Medical University, 2023, 40(12): 2071-2077. DOI: 10.16190/j.cnki.45-1211/r.2023.12.021

高频超声测量参数与早期类风湿关节炎抗风湿疗效的相关性及预测价值分析

Correlation and predictive value of HFUS measurement parameters and anti-rheumatic efficacy of early rheumatoid arthritis

  • 摘要: 目的:探究高频超声(HFUS)测量参数与早期类风湿关节炎(RA)抗风湿疗效的相关性及预测疗效的价值。方法:选取2022年3月至2023年3月安徽省桐城市人民医院收治的97例早期RA患者作为研究组,另选同期97例至少有一个关节炎表现的非RA患者作为对照组。比较两组HFUS测量参数(滑膜厚度、关节积液、血流信号、骨侵蚀评分)、类风湿因子(RF)、血沉(ESR)、C反应蛋白(CRP)水平,分析HFUS测量参数评分与ESR、RF、CRP水平的相关性,研究组均给予抗风湿治疗,比较不同疗效患者治疗前、治疗3个月后HFUS测量参数评分及变化值,分析治疗前后HFUS测量参数评分变化值与抗风湿疗效的相关性,并分析治疗前HFUS测量参数评分预测抗风湿疗效的价值。结果:研究组血流信号、滑膜厚度、骨侵蚀、关节积液评分、ESR及血清RF、CRP水平高于对照组(P<0.05);研究组血流信号、滑膜厚度、骨侵蚀、关节积液评分与RF、ESR、CRP水平呈正相关关系(P<0.05);疗效良好患者治疗前、治疗3个月后滑膜厚度、血流信号、关节积液、骨侵蚀评分低于疗效差患者,各参数评分变化值大于疗效差患者(P<0.05);前滑膜厚度、血流信号、关节积液、骨侵蚀评分预测抗风湿疗效AUC分别为0.771、0.742、0.735、0.741,具有一定预测效能,各评分联合预测的AUC为0.921,大于单独预测的AUC(Z=2.316、2.220、2.887、2.414,P=0.021、0.026、0.004、0.016)。结论:HFUS测量参数可用于早期RA诊断中,为临床早期评估RA活动度及抗风湿疗效提供参考,以针对性展开后续干预治疗,从而改善预后。

     

    Abstract: Objective: To explore the correlation between high frequency ultrasound(HFUS) measurement parameters and the anti-rheumatic efficacy of early rheumatoid arthritis(RA), and the value of predicting the efficacy. Methods: A total of 97 cases of early RA patients admitted to Tongcheng People's Hospital of Anhui Province from March 2022 to March 2023 were selected as the study group, and another 97 cases of non-RA patients with at least one manifestation of arthritis in the same period were selected as the control group. The HFUS measurement parameters(synovial thickness, joint effusion, blood flow signal, bone erosion score), rheumatoid factor(RF), erythrocyte sedimentation rate(ESR), and C-reactive protein(CRP) levels were compared between the two groups. The correlation between HFUS measurement parameter score and ESR, RF, and CRP levels was analyzed. The study group was given anti-rheumatic treatment. The HFUS measurement parameter scores and changes of patients with different curative effects before treatment and after 3 months of treatment were compared, the correlation between the changes of HFUS measurement parameter score before and after treatment and the antirheumatic efficacy was analyzed, and the value of HFUS measurement parameter score before treatment in predicting the anti-rheumatic efficacy was analyzed. Results: The blood flow signal, synovial thickness, bone erosion, joint effusion score, ESR and serum RF, CRP levels in the study group were higher than those in the control group(P<0.05); in the study group, the blood flow signal, synovial thickness, bone erosion and joint effusion scores were positively correlated with RF, ESR and CRP levels(P<0.05); the synovial thickness, blood flow signal, joint effusion and bone erosion scores of patients with good curative effect before treatment and 3 months after treatment were lower than those of patients with poor curative effect, and the changes of each parameter score were greater than those of patients with poor curative effect(P<0.05); the AUC of anterior synovial thickness, blood flow signal, joint effusion and bone erosion score in predicting anti-rheumatic efficacy were 0.771, 0.742, 0.735 and 0.741, respectively, which had a certain predictive efficiency, and the AUC of combined prediction of each score was 0.921, which was greater than that of single prediction(z=2.316, 2.220, 2.887, 2.414, P=0.021, 0.026, 0.004, 0.016). Conclusion: HFUS measurement parameters can be used in the early diagnosis of RA and provide reference for early clinical evaluation of RA activity and anti-rheumatic efficacy, so as to carry out targeted follow-up intervention and improve prognosis.

     

/

返回文章
返回